Time-dependent suppression of melanoma metastases and natural killer cell activation by interferon
- PMID: 3740943
- DOI: 10.1007/BF00407748
Time-dependent suppression of melanoma metastases and natural killer cell activation by interferon
Abstract
The effect of murine alpha/beta interferon (IFN) on experimental metastasis was investigated using B16-F10 melanoma cells. Since the outcome of metastasis of blood-borne tumor cells is mainly determined within the first 24 h after i.v. inoculation of tumor cells, i.p. injection of IFN was focused on this critical early phase. The inhibition of pulmonary metastases by IFN was found to be maximal when given 3 h prior to tumor cell inoculation, while mice with 24-h and 12-h pretreatment and simultaneous IFN treatment also showed a reduction in metastases, but to a lesser extent. However, mice receiving IFN 2 h after tumor cell inoculation did not show any reduction. Tumor cells cultured for 24 h in IFN-containing medium showed no reduction in metastases. Administration of anti-asialo GMl prior to IFN treatment was found to eliminate the inhibitory effect of IFN 3 h pretreatment. However, natural killer (NK) cell activity in vitro measured at 3 h, 13 h and 24 h after IFN administration was enhanced to the same extent, not paralleling the inhibitory effect on pulmonary metastases. These data indicate that prepared host status against blood-borne tumor cells is established by IFN pretreatment, being maximal when injected several hours prior to tumor cell inoculation, and that this effect is substantially dependent on NK cell activity, though the implication of other factors is not excluded.
Similar articles
-
[Antitumor effect of human interferon-alpha A/D in mice (II). Activation of natural killer cells and suppression of metastasis].Gan To Kagaku Ryoho. 1985 Mar;12(3 Pt 1):510-5. Gan To Kagaku Ryoho. 1985. PMID: 2988456 Japanese.
-
Inhibition of experimentally-induced murine metastases by recombinant alpha interferon: correlation between the modulatory effect of interferon treatment on natural killer cell activity and inhibition of metastases.Int J Cancer. 1984 Sep 15;34(3):421-6. doi: 10.1002/ijc.2910340321. Int J Cancer. 1984. PMID: 6480158
-
Inhibition of intravascular mouse melanoma dissemination by recombinant human interferon alpha A/D.Jpn J Cancer Res. 1986 Jan;77(1):80-4. Jpn J Cancer Res. 1986. PMID: 3082819
-
[Control of melanogenesis by glycosylation inhibitors and the inhibitory effect of interferon on melanoma metastasis].Gan To Kagaku Ryoho. 1985 Jun;12(6):1235-44. Gan To Kagaku Ryoho. 1985. PMID: 2408578 Japanese.
-
Endogenous type I interferons as a defense against tumors.Cytokine Growth Factor Rev. 2002 Apr;13(2):111-8. doi: 10.1016/s1359-6101(01)00035-1. Cytokine Growth Factor Rev. 2002. PMID: 11900987 Review.
Cited by
-
The antitumor effects of IFN-alpha are abrogated in a STAT1-deficient mouse.J Clin Invest. 2003 Jul;112(2):170-80. doi: 10.1172/JCI16603. J Clin Invest. 2003. PMID: 12865406 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Miscellaneous